“Typically, when people think about cancer research they think about finding cures, but the goal of this nonprofit is prevention, specifically for people with the BRCA gene … The potential here is transformative.”
– Linsey Davis, Good Morning America
Fact: 1 in 3 people will be diagnosed with cancer in their lifetime, and the numbers are rising. Only prevention can stop this.
HeritX is changing the approach to cancer by putting prevention first. Prevention is the only way to spare our loved ones the trauma of cancer and its treatment.
Fact: People born with a BRCA gene mutation face an up to 90% risk of developing not only one but multiple kinds of cancer.
Millions of families are threatened by inherited BRCA cancer, generation after generation. They urgently need a preventive therapy.
Fact: Despite decades of research, cancer treatment is still agonizing and it takes an average of 15 years to develop new medicines.
March 4th, 2018|Comments Off on Margaret I. Cuomo, MD, joins the HeritX Board of Trustees
Margaret I. Cuomo, MD, joins the HeritX Board of Trustees FLORHAM PARK, NJ (February 28, 2018) – HeritX announces that nationally recognized cancer prevention expert and advocate Margaret I. Cuomo, MD, has joined its Board of [...]
February 20th, 2018|Comments Off on HeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX Board
HeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX Board FLORHAM PARK, NJ (February 20, 2018) – HeritX announces the appointment of Thomas Hofstetter, Chief Executive Officer (CEO) and Founder of [...]
February 16th, 2018|Comments Off on HeritX: Putting Prevention First This National Cancer Prevention Month
HeritX: Putting Prevention First This National Cancer Prevention Month February is National Cancer Prevention Month. It is intended to put cancer squarely in the public eye. The hope is that one day, there will be [...]
December 24th, 2017|Comments Off on HeritX researcher discovers new function for BRCA1
HeritX researcher discovers new function for BRCA1 One of the earliest cancer prevention projects HeritX funded is in the lab of Dr. Ralph Scully at Beth Israel Deaconess Medical Center. We are excited to share [...]